NM_000153.4:c.1884dupA
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_000153.4(GALC):c.1884dupA(p.Trp629MetfsTer9) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. K628K) has been classified as Likely benign.
Frequency
Consequence
NM_000153.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- Krabbe diseaseInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Myriad Women’s Health, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), PanelApp Australia, ClinGen, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000153.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GALC | NM_000153.4 | MANE Select | c.1884dupA | p.Trp629MetfsTer9 | frameshift | Exon 16 of 17 | NP_000144.2 | ||
| GALC | NM_001201401.2 | c.1815dupA | p.Trp606MetfsTer9 | frameshift | Exon 15 of 16 | NP_001188330.1 | |||
| GALC | NM_001201402.2 | c.1806dupA | p.Trp603MetfsTer9 | frameshift | Exon 16 of 17 | NP_001188331.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GALC | ENST00000261304.7 | TSL:1 MANE Select | c.1884dupA | p.Trp629MetfsTer9 | frameshift | Exon 16 of 17 | ENSP00000261304.2 | ||
| GALC | ENST00000393568.8 | TSL:2 | c.1815dupA | p.Trp606MetfsTer9 | frameshift | Exon 15 of 16 | ENSP00000377198.4 | ||
| GALC | ENST00000393569.6 | TSL:2 | c.1806dupA | p.Trp603MetfsTer9 | frameshift | Exon 16 of 17 | ENSP00000377199.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00 AC: 0AN: 248820 AF XY: 0.00
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1458668Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 725840
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Galactosylceramide beta-galactosidase deficiency Pathogenic:3
This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Trp629Metfs*9) in the GALC gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 57 amino acid(s) of the GALC protein. This variant has been observed in individual(s) with Krabbe disease (PMID: 29120458). This variant is also known as 1837insA. ClinVar contains an entry for this variant (Variation ID: 557679). Experimental studies have shown that this variant affects GALC protein function (PMID: 27638593). This variant disrupts the C-terminus of the GALC protein. Other variant(s) that disrupt this region (p.Trp629Cysfs*6) have been determined to be pathogenic (PMID: 11151421, Invitae). This suggests that variants that disrupt this region of the protein are likely to be causative of disease. For these reasons, this variant has been classified as Pathogenic.
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at